Search Results - "Sharman, P."

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies by ADVANI, Ranjana H, BUGGY, Joseph J, SUKBUNTHERNG, Juthamas, IZUMI, Raquel, HAMDY, Ahmed, HEDRICK, Eric, FOWLER, Nathan H, SHARMAN, Jeff P, SMITH, Sonali M, BOYD, Thomas E, GRANT, Barbara, KOLIBABA, Kathryn S, FURMAN, Richard R, RODRIGUEZ, Sara, CHANG, Betty Y

“…Survival and progression of mature B-cell malignancies depend on signals from the B-cell antigen receptor, and Bruton tyrosine kinase (BTK) is a critical…”
Get full text

Survival Trends and Syndromic Esophageal Atresia by Tan Tanny, Sharman P, Beck, Cara, King, Sebastian K, Hawley, Alisa, Brooks, Jo-Anne, McLeod, Elizabeth, Hutson, John M, Teague, Warwick J

“…Presence of a syndrome (or association) is predictive of poor survival in esophageal atresia (EA). However, most reports rely on historical patient outcomes,…”
Get full text

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma by Tilly, Hervé, Morschhauser, Franck, Sehn, Laurie H, Friedberg, Jonathan W, Trněný, Marek, Sharman, Jeff P, Herbaux, Charles, Burke, John M, Matasar, Matthew, Rai, Shinya, Izutsu, Koji, Mehta-Shah, Neha, Oberic, Lucie, Chauchet, Adrien, Jurczak, Wojciech, Song, Yuqin, Greil, Richard, Mykhalska, Larysa, Bergua-Burgués, Juan M, Cheung, Matthew C, Pinto, Antonio, Shin, Ho-Jin, Hapgood, Greg, Munhoz, Eduardo, Abrisqueta, Pau, Gau, Jyh-Pyng, Hirata, Jamie, Jiang, Yanwen, Yan, Mark, Lee, Calvin, Flowers, Christopher R, Salles, Gilles

“…The treatment outcome for diffuse large B-cell lymphoma has not been improved in nearly 20 years. However, the replacement of vincristine in R-CHOP with…”
Get full text

Medical and surgical management of pediatric perianal crohn's disease: A systematic review by Forsdick, Victoria K., Tan Tanny, Sharman P., King, Sebastian K.

“…The timely management of pediatric Crohn's disease (CD), and specifically perianal CD, is important owing to the possible adverse effects on growth,…”
Get full text

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial by Zelenetz, Andrew D, Prof, Barrientos, Jacqueline C, MD, Brown, Jennifer R, MD, Coiffier, Bertrand, Prof, Delgado, Julio, MD, Egyed, Miklós, Prof, Ghia, Paolo, MD, Illés, Árpád, Prof, Jurczak, Wojciech, MD, Marlton, Paula, MBBS, Montillo, Marco, MD, Morschhauser, Franck, Prof, Pristupa, Alexander S, MD, Robak, Tadeusz, Prof, Sharman, Jeff P, MD, Simpson, David, MBChB, Smolej, Lukáš, MD, Tausch, Eugen, MD, Adewoye, Adeboye H, MD, Dreiling, Lyndah K, MD, Kim, Yeonhee, PhD, Stilgenbauer, Stephan, Prof, Hillmen, Peter, Prof

“…Summary Background Bendamustine plus rituximab is a standard of care for the management of patients with relapsed or refractory chronic lymphocytic leukaemia…”
Get full text

Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia by Rogers, Kerry A., Thompson, Philip A., Allan, John N., Coleman, Morton, Sharman, Jeff P., Cheson, Bruce D., Jones, Daniel, Izumi, Raquel, Frigault, Melanie M., Quah, Cheng, Raman, Rakesh K., Patel, Priti, Wang, Min Hui, Kipps, Thomas J.

“…B-cell receptor signalling inhibition by targeting Bruton tyrosine kinase (BTK) is effective in treating chronic lymphocytic leukemia (CLL). The BTK inhibitor…”
Get full text

Surgical management of perianal abscess in neonates and infants by Tan Tanny, Sharman P., Wijekoon, Naveen, Nataraja, Ramesh M., Lynch, Amiria, Pacilli, Maurizio

“…Background The optimal management of perianal abscess in neonates and infants remains unclear, including the need for laying open of the fistula and the role…”
Get full text

Current surgical practice in pediatric ulcerative colitis: A systematic review by Tan Tanny, Sharman P., Yoo, Minjung, Hutson, John M., Langer, Jacob C., King, Sebastian K.

“…Surgical management of adult ulcerative colitis (UC) is well-studied, but not readily applicable to children. Restorative proctocolectomy with ileal pouch-anal…”
Get full text

Esophago‐gastric junction findings on high resolution impedance manometry in children with esophageal atresia by Tan Tanny, Sharman P., Senior, Nicholas D., Comella, Assia, McCall, Lisa, Hutson, John M., Finch, Sue, Safe, Mark, Teague, Warwick J., Omari, Taher I., King, Sebastian K.

“…Objectives Using high resolution impedance manometry (HRIM), this study characterized the esophago‐gastric junction (EGJ) dynamics in children with esophageal…”
Get full text

Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older by Forero-Torres, Andres, Holkova, Beata, Goldschmidt, Jerome, Chen, Robert, Olsen, Gregg, Boccia, Ralph V., Bordoni, Rodolfo E., Friedberg, Jonathan W., Sharman, Jeff P., Palanca-Wessels, Maria Corinna, Wang, Yinghui, Yasenchak, Christopher A.

“…Outcomes in older patients with Hodgkin lymphoma (HL) tend to be poor following conventional chemotherapy regimens. Treatment-related toxicity is significant…”
Get full text

H-type congenital tracheoesophageal fistula: Insights from 70 years of The Royal Children's Hospital experience by Taghavi, Kiarash, Tan Tanny, Sharman P, Hawley, Alisa, Brooks, Jo-Anne, Hutson, John M, Teague, Warwick J, King, Sebastian K, Nightingale, Michael

“…The long-term outcomes of H-type tracheoesophageal fistula (TOF), an uncommon variant of esophageal atresia/tracheoesophageal fistula (OA/TOF), are rarely…”
Get full text

Quality of life assessment in esophageal atresia patients: a systematic review focusing on long-gap esophageal atresia by Tan Tanny, Sharman P., Comella, Assia, Hutson, John M., Omari, Taher I., Teague, Warwick J., King, Sebastian K.

“…Children born with esophageal atresia (EA) have inherent abnormalities in esophageal motility which may impact upon patient and family Quality of Life (QoL)…”
Get full text

Distinguishing Lyme from septic knee monoarthritis in Lyme disease-endemic areas by Deanehan, Julia K, Kimia, Amir A, Tan Tanny, Sharman P, Milewski, Matthew D, Talusan, Paul G, Smith, Brian G, Nigrovic, Lise E

“…Because Lyme and septic arthritis may present similarly, we sought to identify children with knee monoarthritis at low risk for septic arthritis who may not…”
Get full text

The burden of esophageal dilatations following repair of esophageal atresia by Campos, Jose, Tan Tanny, Sharman P., Kuyruk, Sema, Sekaran, Prabhu, Hawley, Alisa, Brooks, Jo-Anne, Bekhit, Elhamy, Hutson, John M., Crameri, Joseph, McLeod, Elizabeth, Teague, Warwick J., King, Sebastian K.

“…To describe the burden of esophageal dilatations in patients following esophageal atresia (EA) repair. A retrospective review was performed at The Royal…”
Get full text

Cost-Effectiveness of Thrombolysis Within 4.5 Hours of Acute Ischemic Stroke: Experience From Australian Stroke Center by Tan Tanny, Sharman P, Busija, Lucy, Liew, Danny, Teo, Sarah, Davis, Stephen M, Yan, Bernard

“…BACKGROUND AND PURPOSE—Previous economic studies outside Australia have demonstrated that patients treated with tissue-type plasminogen activator (tPA) within…”
Get full text

Quality of Life Outcomes in Primary Caregivers of Children with Esophageal Atresia by Tan Tanny, Sharman P., Trajanovska, Misel, Muscara, Frank, Hutson, John M., Hearps, Stephen, Omari, Taher I., Teague, Warwick J., King, Sebastian K.

“…To investigate the quality of life (QoL) impact on primary caregivers of children with esophageal atresia. We used a prospective cohort study design, inviting…”
Get full text

Esophageal morbidity in patients following repair of esophageal atresia: A systematic review by Comella, Assia, Tan Tanny, Sharman P., Hutson, John M., Omari, Taher I., Teague, Warwick J., Nataraja, Ramesh M., King, Sebastian K.

“…Esophageal atresia (EA) is a life-threatening congenital condition, affecting one in 2600 newborns. Morbidity remains high, with many patients experiencing…”
Get full text

A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib by Mato, Anthony R, Tang, Boxiong, Azmi, Soraya, Yang, Keri, Zhang, Xiaojuan, Stern, Jennifer C, Hedrick, Eric, Huang, Jane, Sharman, Jeff P

“…Among patients with chronic lymphocytic leukemia (CLL) with deletion 17p (del[17p]), evidence from clinical trials for the effectiveness of single-agent…”
Get full text

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial by O'Brien, Susan, Prof, Furman, Richard R, MD, Coutre, Steven E, Prof, Sharman, Jeff P, MD, Burger, Jan A, MD, Blum, Kristie A, MD, Grant, Barbara, MD, Richards, Donald A, MD, Coleman, Morton, Prof, Wierda, William G, MD, Jones, Jeffrey A, MD, Zhao, Weiqiang, MD, Heerema, Nyla A, Prof, Johnson, Amy J, PhD, Izumi, Raquel, PhD, Hamdy, Ahmed, MD, Chang, Betty Y, PhD, Graef, Thorsten, MD, Clow, Fong, ScD, Buggy, Joseph J, PhD, James, Danelle F, MD, Byrd, John C, Prof

“…Summary Background Chemoimmunotherapy has led to improved numbers of patients achieving disease response, and longer overall survival in young patients with…”
Get full text

Predictors of Mortality after Primary Discharge from Hospital in Patients with Esophageal Atresia by Tan Tanny, Sharman P., Fearon, Edward, Hawley, Alisa, Brooks, Jo-Anne, Comella, Assia, Hutson, John M., Teague, Warwick J., Pellicano, Anastasia, King, Sebastian K.

“…To describe esophageal atresia mortality rates and their associations in our cohort. Patients with esophageal atresia, managed at The Royal Children's…”
Get full text